MUMBAI:BDR Pharmaceutical today announces the launch of 80mg advanced version of its Enzalutamide drug. BDR Pharma had earlier received approval…
Overall mortality rates continue to decline, according to the most recent Annual Report to the Nation on the Status of…
Men with inflammatory bowel disease (IBD) are four to five times at higher risk of being diagnosed with prostate cancer,…
LONDON: The European Medicines Agency (EMA) has concluded its review of the cancer medicine Xofigo (radium-223 dichloride), and has recommended…
Prostate cancer is one of the most common types of cancer affecting men in the U.S. Although deemed survivable, it…
A recent breakthrough in high-intensity focused ultrasound therapy (HIFU) technology has proven its use as an effective cancer treatment. A…
This website uses cookies.